Retraction notice to "gC1qR expression in chimpanzees with resolved and chronic infection: Potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection" [Virology 346 (2006) 324-327] (DOI:10.1016/j.virol.2005.11.020);GC1qR expression in chimpanzees with resolved and chronic infection: Potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection

Virology

Volumn 346, Issue 2, 2006, Pages 324-337

  Yao, Zhi Qiang ^a   Shata, Mohamed Tarek ^b   Tricoche, Nancy ^c   Shan, Mei Mei ^c   Brotman, Betsy ^c   Pfahler, Wolfram ^c   Hahn, Young S ^a   Prince, Alfred M ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c NEW YORK BLOOD CENTER   (United States)

Author keywords

Core protein; gC1qR; HCV; Immunosuppression; T cells; Viral persistence

Indexed keywords

COMPLEMENT COMPONENT C1Q;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CELL SURFACE; CHIMPANZEE; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANIMALIA; HEPATITIS C VIRUS; PAN; PAN TROGLODYTES;

EID: 33644819436     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.09.005     Document Type: Erratum

References (47)

1. M.J. Alter Epidemiology of hepatitis C Hepatology 26 3 Suppl. 1 1997 62S 65S
2. R.E. Blanton, E.A. Salam, H.C. Kariuki, P. Magak, L.K. Silva, E.M. Muchiri, F. Thiongo, I.E. Abdel-Meghid, A.E. Butterworth, M.G. Reis, and J.H. Ouma Population-based differences in Schistosoma mansoni- and hepatitis C-induced disease J. Infect. Dis. 185 2002 1644 1649
3. L. Braun, B. Ghebrehiwet, and P. Cossart gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes EMBO J. 19 2000 1458 1466
4. R. Bruni, and B. Roizman Open reading frame P-A herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA Proc. Natl. Acad. Sci. U.S.A. 93 1996 10423 10427
5. K.M. Chang, B. Rehermann, J.G. McHutchison, C. Pasquinelli, S. Southwood, A. Sette, and F.V. Chisari Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus J. Clin. Invest. 100 1997 2376 2385
6. A. Chen, S. Gaddipati, Y. Hong, D.J. Volkman, E.I. Peerschke, and B. Ghebrehiwet Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation J. Immunol. 153 1994 1430 1440
7. S. Cooper, A.L. Erickson, E.J. Adams, J. Kansopon, A.J. Weiner, D.Y. Chien, M. Houghton, P. Parham, and C.M. Walker Analysis of a successful immune response against hepatitis C virus Immunity 10 1999 439 449
8. A.M. Di Bisceglie Hepatitis C Lancet 351 1998 351 355
9. A.L. Eisen-Vandervelde, Z.Q. Yao, and Y.S. Hahn The molecular basis of HCV-mediated immune dysregulation Clin. Immunol. 111 2004 16 21
10. P. Farci, H.J. Alter, S. Govindarajan, D.C. Wong, R. Engle, R.R. Lesniewski, I.K. Mushahwar, S.M. Desai, R.H. Miller, and N. Ogata Lack of protective immunity against reinfection with hepatitis C virus Science 258 1992 135 140
11. J.T. Gerlach, H.M. Diepolder, M.C. Jung, N.H. Gruener, W.W. Schraut, R. Zachoval, R. Hoffmann, C.A. Schirren, T. Santantonio, and G.R. Pape Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C Gastroenterology 117 1999 933 941
12. B. Ghebrehiwet, G.S. Habicht, and G. Beck Interaction of C1q with its receptor on cultured cell lines induces an anti-proliferative response Clin. Immunol. Immunopathol. 54 1990 148 160
13. B. Ghebrehiwet, B.L. Lim, R. Kumar, X. Feng, and E.I. Peerschke gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection Immunol. Rev. 180 2001 65 77
14. N.H. Gruner, T.J. Gerlach, M.C. Jung, H.M. Diepolder, C.A. Schirren, W.W. Schraut, R. Hoffmann, R. Zachoval, T. Santantonio, M. Cucchiarini, A. Cerny, and G.R. Pape Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C J. Infect. Dis. 181 2000 1528 1536
15. D.J. Kittlesen, K.A. Chianese-Bullick, Z.Q. Yao, T.J. Braciale, and Y.S. Hahn Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation J. Clin. Invest. 106 2000 1239 1249
16. M.K. Large, D.J. Kittlesen, and Y.S. Hahn Suppression of host immune response by the core protein of hepatitis C virus, possible implications for hepatitis C virus persistence J. Immunol. 162 1999 931 938
17. M. Lechmann, R.P. Woitas, B. Langhans, R. Kaiser, H.G. Ihlenfeldt, G. Jung, T. Sauerbruch, and U. Spengler Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C J. Hepatol. 31 1999 971 978
18. F. Lechner, D.K. Wong, P.R. Dunbar, R. Chapman, R.T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B.D. Walker Analysis of successful immune responses in persons infected with hepatitis C virus J. Exp. Med. 191 2000 1499 1512
19. J.H. Lee, G. Teuber, M. von Wagner, W.K. Roth, and S. Zeuzem Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus J. Med. Virol. 60 2000 264 268
20. Y.F. Liaw Role of hepatitis C virus in dual and triple hepatitis virus infection Hepatology 22 1995 1101 1108
21. Z.X. Liu, H. Nishida, J.W. He, M.M. Lai, N. Feng, and G. Dennert Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity J. Virol. 76 2002 990 997
22. Y. Luo, H. Yu, and B.M. Peterlin Cellular protein modulates effects of human immunodeficiency virus type 1 Rev J. Virol. 68 1994 3850 3856
23. P. Maillard, K. Krawczynski, J. Nitkiewicz, C. Bronnert, M. Sidorkiewicz, P. Gounon, J. Dubuisson, G. Faure, R. Crainic, and A. Budkowska Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients J. Virol. 75 2001 8240 8250
24. O.V. Masalova, S.N. Atanadze, E.I. Samokhvalov, N.V. Petrakova, T.I. Kalinina, V.D. Smirnov, Y.E. Khudyakov, H.A. Fields, and A.A. Kushch Detection of hepatitis C virus core protein circulating within different virus particle populations J. Med. Virol. 55 1998 1 6
25. D.A. Matthews, and W.C. Russell Adenovirus core protein V interacts with p32-a protein which is associated with both the mitochondria and the nucleus J. Gen. Virol. 79 1998 1677 1685
26. G. Missale, R. Bertoni, V. Lamonaca, A. Valli, M. Massari, C. Mori, M.G. Rumi, M. Houghton, F. Fiaccadori, and C. Ferrari Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J. Clin. Invest. 98 1996 706 714
27. A. Mohamed, A. Elsheikh, Z. Ghandour, and M.A.I. Karawi Impact of hepatitis C virus infection on schistosomal liver disease Hepatogastroenterology 45 1998 1492 1496
28. T. Nguyen, B. Ghebrehiwet, and E.I. Peerschke Staphylococcus aureus protein A recognizes platelet gC1qR/p33, a novel mechanism for staphylococcal interactions with platelets Infect. Immun. 68 2000 2061 2068
29. R. Pellicano, N. Leone, M. Berrutti, M.A. Cutufia, M. Fiorentino, M. Rizzetto, and A. Ponzetto Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis J. Hepatol. 33 2000 648 650
30. R.B. Ray, and R. Ray Hepatitis C virus core protein, intriguing properties and functional relevance FEMS Microbiol. Lett. 202 2001 149 156
31. B. Rehermann, K.M. Chang, J.G. McHutchison, R. Kokka, M. Houghton, and F.V. Chisari Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection J. Clin. Invest. 98 1996 1432 1440
32. H.R. Rosen, D.J. Hinrichs, D.R. Gretch, M.J. Koziel, S. Chou, M. Houghton, J. Rabkin, C.L. Corless, and H.G. Bouwer Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation Gastroenterology 117 1999 926 932
33. P. Sarobe, J.J. Lasarte, N. Casares, A. Lopez-Diaz de Cerio, E. Baixeras, P. Labarga, N. Garcia, F. Borras-Cuesta, and J. Prieto Abnormal priming of CD4 (+) T cells expressing hepatitis C virus core and E1 proteins J. Virol. 76 2002 5062 5070
34. M.T. Shata, D.D. Anthony, N.L. Carlson, L. Andrus, B. Brotman, N. Tricoche, P. McCormack, and A. Prince Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees J. Viral Hepatitis 9 2002 400 410
35. K. Sugimoto, F. Ikeda, J. Stadanlick, F.A. Nunes, H.J. Alter, and K.M. Chang Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection Hepatology 38 2003 1437 1448
36. K. Sugimoto, E.K. David, I. Fusao, D. Jin, S. Jonathan, A.N. Frederick, J.A. Harvey, and M.C. Kyong Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection J. Virol. 79 2005 6976 6983
37. A. Takaki, M. Wiese, G. Maertens, E. Depla, U. Seifert, A. Liebetrau, J.L. Miller, M.P. Manns, and B. Rehermann Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nat. Med. 6 2000 578 582
38. R. Thimme, D. Oldach, K.M. Chang, C. Steiger, S.C. Ray, and F.V. Chisari Determinant of viral clearance and persistence during acute hepatitis C virus infection J. Exp. Med. 19 2001 1359 1406
39. S.L. Tsai, and S.N. Huang T cell mechanisms in the immunopathogenesis of viral hepatitis B and C J. Gastroenterol. Hepatol. 12 1997 S227 S235
40. Y. Wang, J.E. Finan, J.M. Middeldrop, and S.D. Hayward P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus Virology 236 1997 18 29
41. H. Wedemeyer, X.S. He, M. Nascimbeni, A.R. Davis, H.B. Greenberg, J.H. Hoofnagle, T.J. Liang, H. Alter, and B. Rehermann Impaired effector function of hepatitis C virus-specific CD8+T cells in chronic hepatitis C virus infection J. Immunol. 169 2002 3447 3458
42. A. Widell, V. Molnegren, F. Pieksma, M. Calmann, J. Peterson, and S.R. Lee Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase Transfus. Med. 12 2002 107 113
43. Z.Q. Yao, D.T. Nguyen, A.I. Hiotellis, and Y.S. Hahn Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway J. Immunol. 167 2001 5264 5272
44. Z.Q. Yao, S. Ray, A. Eisen-Vandervelde, S. Waggoner, and Y.S. Hahn Hepatitis C virus, immunosuppression by complement regulatory pathway Viral Immunol. 14 2001 277 295
45. kip1 Virology 314 2003 271 282
46. + T cells leads to impaired activation of Lck and Akt J. Virol. 78 2004 6409 6419
47. Z.Q. Yao, S.N. Waggener, M.W. Cruise, C. Hall, X.F. Xie, D.W. Oldach, and Y.S. Hahn SOCS1 and SOCS3 are targeted by hepatitis c virus core/gC1qR ligation to inhibit T-cell function J. Virol. 79 2005 15417 15429